Geron Patent definition

Geron Patent means a Patent which claims a process, method, apparatus, composition of matter, compound, chemical, material, or article of manufacture useful in the Field (or the discovery, development, manufacture and clinical use of compounds having potential activity in the Field), which Patent is Controlled by Geron or its Affiliates during the term of this Agreement, including Geron's undivided interest in any Patent jointly owned with KH or P&U.
View Source
Geron Patent means a Patent which claims a process, method, apparatus, composition of matter, compound, chemical, material, or article of manufacture useful in the Field (or the discovery, development, manufacture and clinical use of compounds having * Certain portions of this Exhibit have been omitted for which confidential treatment has been requested and filed separately with the Securities and Exchange Commission. 6 potential activity in the Field), which Patent is Controlled by Geron or its Affiliates during the term of this Agreement, including Geron's undivided interest in any Joint Patent. Set forth in EXHIBIT 1.12 is a list of all current Geron Patents.
View Source

Examples of Geron Patent in a sentence

  • Section 13.4 of the KH Agreement is hereby amended to provide that the right to institute, prosecute and control any action or proceeding with respect to the infringement or defense of a Geron Patent, Kyowa Hakko Patent or Joint Patent relating to a Product shall be as provided in the Three-Way Agreement.

  • Geron Patent which it receives as a patent owner pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984 (hereinafter called the "Act"), including but not limited to notices pursuant to Section Section 101 and 103 of the Act from persons who have filed an abbreviated NDA ("ANDA").

  • Should Geron determine not to file, prosecute, issue or maintain a Geron Patent or Joint Patent in the Field, it will timely grant any necessary authority it may legally grant to P&U to file, prosecute, issue or maintain such Patent in the name of Geron in the Field, all at the expense of P&U.

  • Merck and Geron may agree to jointly undertake a legal action to defend or enforce the Geron Patent Rights or Geron Know-How in the Field.

  • This Agreement shall commence as of the Effective Date and, unless terminated earlier in whole or in party by action under another Section of the Article, shall continue in effect until the later of (i) the last to expire, on a country-by-country basis, Geron Patent or BMG Patent, or (ii) termination of all royalty obligations under Article 7.

  • No settlement or other concession of any action related to Geron Patent Rights initiated by Merck as permitted by this paragraph shall be entered into without Geron’s written agreement.

  • Within five (5) business days of receipt of such certification, Geron shall provide Merck with a copy of such certification and Geron shall timely inform Merck if it elects not to exercise such first right and, subject to any other obligations of Geron existing as of the Effective Date, Merck shall thereafter have the right to initiate and prosecute such action to terminate infringement, of Geron Patent Rights, or misappropriation or misuse of Geron Know-How in the names of Merck and, if necessary, Geron.

  • In the United States only, to the extent a continuation-in-part application is filed on a Geron Patent for an invention described in subsection (iii) below, BMG hereby assigns its entire right, title and interest in any such continuation-in-part application to Geron, and Geron hereby grants to BMG, subject to the terms of this Agreement, perpetual worldwide, non-exclusive, transferable, royalty free, fully paid-up license to use such Patents for any purpose.

  • As between Merck and G▇▇▇▇, ▇▇▇▇▇ shall have the right to initiate and prosecute such legal action at its own expense, and to control the defense of any declaratory judgment action, relating to Geron Patent Rights.

  • Notwithstanding the non-exclusive nature of such license, in order to preserve the exclusive nature of Merck’s option pursuant to Section 3.2.3, Geron shall not grant any license in the Territory to any Third Party under Geron Patent Rights, Geron Know-How, Geron Program Patent Rights, Geron’s interest in Joint Program Patent Rights or Geron’s interest in Program Know-How to develop or commercialize DC Products, DC/Non-DC Therapies or DC/Adeno/DNA Therapies in the Field during such *-year period.

Related to Geron Patent

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Patent Rights means all patents and patent applications (which for the purpose of this Agreement shall be deemed to include certificates of invention and applications for certificates of invention), including all divisionals, continuations, substitutions, continuations-in-part, re-examinations, reissues, additions, renewals, revalidations, extensions, registrations, pediatric exclusivity periods and supplemental protection certificates and the like of any such patents and patent applications, and any and all foreign equivalents of the foregoing.

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Licensed Patent means Stanford's rights in U.S. Patent Application, Serial Number , filed , any foreign patent application corresponding thereto, and any divisional, continuation, or reexamination application, extension, and each patent that issues or reissues from any of these patent applications. Any claim of an unexpired Licensed Patent is presumed to be valid unless it has been held to be invalid by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken. “Licensed Patent” excludes any continuation-in-part (CIP) patent application or patent.